GCIA
JNCE

Gabelli & Co Investment Advisers’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-425,100
Closed -$786K – 313
2023
Q1 		$786K Buy
+425,100
New +$786K 0.15% 86